The 1975 International Conference on Recombinant DNA Molecules held at the Asilomar Conference Center in California has cast a long shadow. Groundbreaking at the time, the meeting of scientists to ...

In 1986, the Recombivax HB vaccine for hepatitis B was approved for human use in several countries, the culmination of research started by William Rutter, Pablo Valenzuela and colleagues in 1979 on ...

Matthew Cobb is professor emeritus at the University of Manchester, UK, and author of The Genetic Age (Profile Books, 2022). On 24 February 1975, some 150 people met at the Asilomar Conference Grounds ...

Recombinant antibody technology has been leveraged to mitigate a range of common problems associated with hybridoma platforms, helping to facilitate the development of an entirely new class of ...

Gene editing was a new idea in the mid-1970s. So when two of America's most prestigious research institutions planned a new facility for work in recombinant DNA, the technology that lets scientists ...

The development of early monoclonal antibody (mAb) therapies centered around the hybridoma platform requires the production of target antigen or immunogen and animal immunizations. This means there ...

Researchers at the USC School of Pharmacy indicate that recombinant DNA technology may allow for oral administration of drugs that previously could only be given by injection. LOS ANGELES, May 6 - ...